Preparation method for adenovirus p53-loaded dendritic cell vaccine
AssigneeScinosen (Shenzhen) Gene Industry Development Co. Ltd.
InventorsDiosdado Bautista, Wei Xu, Aiguo Hu, Mao Ye
Life of this patent
Estimating the term…
Loading patent…
AssigneeScinosen (Shenzhen) Gene Industry Development Co. Ltd.
InventorsDiosdado Bautista, Wei Xu, Aiguo Hu, Mao Ye
Estimating the term…
The present disclosure belongs to the field of biotechnology, and specifically relates to a preparation method for an adenovirus p53 (Ad-p53)-loaded dendritic cell (DC) vaccine. The present disclosure includes steps of peripheral blood collection and peripheral blood mononuclear cell (PBMC) separation, PBMC sorting, DC activation, Ad-P53-transfected DC and DC vaccine preparation. P53 can be expressed on a surface of DC as a tumor-associated antigen (TAA) through DC purification, specific multiplicity of infection (MOI) and infection modes, and the Ad-P53-transfected DC has obvious antigen presentation effect, which can be used as a vaccine to activate T cells to kill tumors.
A preparation method for an adenovirus p53 (Ad-p53)-loaded dendritic cell (DC) vaccine, comprising the following steps:
Dependencies are inferred from the claim text.